Nvidia’s strategic investments in smaller AI firms and companies specializing in various sectors have significantly impacted their shares in premarket trading. Among the notable investments, Arm Holdings, a fellow chip designer, received the largest investment of $147.3 million from Nvidia. This move has further strengthened Arm’s position, leading to a 2.6% increase in its shares. Recursion Pharmaceuticals, a biotech company, and SoundHound AI, a voice AI platform, also experienced substantial gains of 16.5% and 72%, respectively, after receiving investments of nearly $76 million and $3.7 million from Nvidia. Additionally, Nano-X Imaging, an Israel-based medical device company utilizing AI for report analysis, witnessed a significant rise of 42.5% in its shares. Nvidia’s diverse investments across sectors like healthcare, biotech, and AI technology highlight its commitment to staying at the forefront of innovation and driving growth in emerging markets. The company’s recent surge in valuation has propelled it to become the third most valuable U.S. company, surpassing Alphabet and Amazon.com.